UCP2 and obesity due to melanocortin 4 receptor deficiency: A protective function for UCP2 has been proposed for a range of diseases, such as ischemia [26], [32], brain trauma [32], epilepsy [58]–[60], Parkinson’s disease [61], diabetes [18], obesity [62], and anorexia nervosa [63].